NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
The current price of XSNX is $0 USD — it has increased by +0% in the past 24 hours. Watch Novaccess Global stock price performance more closely on the chart.
What is Novaccess Global stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Novaccess Global stocks are traded under the ticker XSNX.
What is Novaccess Global market cap?▼
Today Novaccess Global has the market capitalization of 6,165.2
What is Novaccess Global revenue for the last year?▼
Novaccess Global revenue for the last year amounts to 0 USD.
What is Novaccess Global net income for the last year?▼
XSNX net income for the last year is -5.32M USD.
How many employees does Novaccess Global have?▼
As of April 05, 2026, the company has 3 employees.
In which sector is Novaccess Global located?▼
Novaccess Global operates in the Health Care sector.
When did Novaccess Global complete a stock split?▼
The last stock split for Novaccess Global was on August 26, 2020 with a ratio of 1:1000.
Where is Novaccess Global headquartered?▼
Novaccess Global is headquartered in Chagrin Falls, US.